113 related articles for article (PubMed ID: 12405240)
1. Time trends in the HERS secondary prevention trial: much ado about nothing?
Derry PS
J Am Med Womens Assoc (1972); 2002; 57(4):215-6. PubMed ID: 12405240
[TBL] [Abstract][Full Text] [Related]
2. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.
Hulley S; Grady D; Bush T; Furberg C; Herrington D; Riggs B; Vittinghoff E
JAMA; 1998 Aug; 280(7):605-13. PubMed ID: 9718051
[TBL] [Abstract][Full Text] [Related]
3. Estrogen plus progestin and the risk of coronary heart disease.
Manson JE; Hsia J; Johnson KC; Rossouw JE; Assaf AR; Lasser NL; Trevisan M; Black HR; Heckbert SR; Detrano R; Strickland OL; Wong ND; Crouse JR; Stein E; Cushman M;
N Engl J Med; 2003 Aug; 349(6):523-34. PubMed ID: 12904517
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).
Grady D; Herrington D; Bittner V; Blumenthal R; Davidson M; Hlatky M; Hsia J; Hulley S; Herd A; Khan S; Newby LK; Waters D; Vittinghoff E; Wenger N;
JAMA; 2002 Jul; 288(1):49-57. PubMed ID: 12090862
[TBL] [Abstract][Full Text] [Related]
5. [Health symptom-free women do not need preventive hormone replacement therapy. The risks outweigh the benefits; a large trial prematurely interrupted in the USA].
von Schoultz B
Lakartidningen; 2002 Aug; 99(34):3276-8. PubMed ID: 12362844
[No Abstract] [Full Text] [Related]
6. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
Rapp SR; Espeland MA; Shumaker SA; Henderson VW; Brunner RL; Manson JE; Gass ML; Stefanick ML; Lane DS; Hays J; Johnson KC; Coker LH; Dailey M; Bowen D;
JAMA; 2003 May; 289(20):2663-72. PubMed ID: 12771113
[TBL] [Abstract][Full Text] [Related]
7. The relation of postmenopausal hormone therapy to serum uric acid and the risk of coronary heart disease events: the Heart and Estrogen-Progestin Replacement Study (HERS).
Simon JA; Lin F; Vittinghoff E; Bittner V;
Ann Epidemiol; 2006 Feb; 16(2):138-45. PubMed ID: 16039873
[TBL] [Abstract][Full Text] [Related]
8. Mammographic breast density during hormone replacement therapy: effects of continuous combination, unopposed transdermal and low-potency estrogen regimens.
Lundström E; Wilczek B; von Palffy Z; Söderqvist G; von Schoultz B
Climacteric; 2001 Mar; 4(1):42-8. PubMed ID: 11379377
[TBL] [Abstract][Full Text] [Related]
9. The Heart and Estrogen/Progestin Replacement Study: what have we learned and what questions remain?
Wells G; Herrington DM
Drugs Aging; 1999 Dec; 15(6):419-22. PubMed ID: 10641952
[TBL] [Abstract][Full Text] [Related]
10. Heart and Estrogen/progestin Replacement Study (HERS): design, methods, and baseline characteristics.
Grady D; Applegate W; Bush T; Furberg C; Riggs B; Hulley SB
Control Clin Trials; 1998 Aug; 19(4):314-35. PubMed ID: 9683309
[TBL] [Abstract][Full Text] [Related]
11. HRT: forever or never?
Corson SL
Int J Fertil Womens Med; 2002; 47(4):150-1. PubMed ID: 12199410
[No Abstract] [Full Text] [Related]
12. Women seek alternatives to hormone replacement therapy.
Altern Ther Health Med; 2002; 8(5):27. PubMed ID: 12233798
[No Abstract] [Full Text] [Related]
13. Discussing breast cancer and hormone replacement therapy with women.
Batur P; Thacker HL; Moore HC
Cleve Clin J Med; 2002 Nov; 69(11):838, 840, 843-4 passim. PubMed ID: 12430969
[TBL] [Abstract][Full Text] [Related]
14. Good science or good marketing?
Head K
Altern Med Rev; 2002 Aug; 7(4):274-5. PubMed ID: 12197780
[No Abstract] [Full Text] [Related]
15. Combination hormone replacement therapy and dementia.
Wooltorton E
CMAJ; 2003 Jul; 169(2):133. PubMed ID: 12874164
[No Abstract] [Full Text] [Related]
16. Failure of estrogen plus progestin therapy for prevention.
Fletcher SW; Colditz GA
JAMA; 2002 Jul; 288(3):366-8. PubMed ID: 12117403
[No Abstract] [Full Text] [Related]
17. Balancing between observational studies and randomized trials in prevention of coronary heart disease by estrogen replacement: HERS study was no revolution.
Ylikorkala O
Acta Obstet Gynecol Scand; 2000 Dec; 79(12):1029-36. PubMed ID: 11130082
[No Abstract] [Full Text] [Related]
18. What pharmacists need to know about the women's health initiative estrogen plus progestin trial.
Saseen JJ; Hansen LB
Am J Health Syst Pharm; 2003 Feb; 60(3):281-4. PubMed ID: 12613239
[No Abstract] [Full Text] [Related]
19. Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen/Progestin Replacement Study (HERS).
Herrington DM; Vittinghoff E; Lin F; Fong J; Harris F; Hunninghake D; Bittner V; Schrott HG; Blumenthal RS; Levy R;
Circulation; 2002 Jun; 105(25):2962-7. PubMed ID: 12081988
[TBL] [Abstract][Full Text] [Related]
20. Hormone replacement therapy should be administered as secondary prevention of coronary artery disease.
Spencer AP
Pharmacotherapy; 2000 Sep; 20(9):1028-33. PubMed ID: 10999493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
